CDX-1402

N/A

Report date: 2022/03/10 10:42:44

Base Information

Drug NameCDX-1402
Drug Alias NameCDX-1402
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunostimulantsDendritic cells stimulantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects +[5] 
TargetsLymphocyte antigen 75Receptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending
Highest Status in ChinaN/A
Originator CompaniesCelldex Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelldex Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A